Cardlytics Inc [CDLX] stock prices are up 0.32% to $3.16 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CDLX shares have gain 1.61% over the last week, with a monthly amount drifted -4.53%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cardlytics Inc [NASDAQ: CDLX] stock has seen the most recent analyst activity on August 16, 2024, when Northland Capital downgraded its rating to a Market Perform but kept the price target unchanged to $5 for it. Previously, BofA Securities downgraded its rating to Underperform on August 15, 2024, and dropped its price target to $3.50. On August 08, 2024, downgrade downgraded it’s rating to Hold. Lake Street downgraded its rating to a Hold and decreased its price target to $5 on August 08, 2024. Craig Hallum downgraded its rating to a Hold. In a note dated June 18, 2024, Northland Capital initiated an Outperform rating and provided a target price of $14 on this stock.
The stock price of Cardlytics Inc [CDLX] has been fluctuating between $2.89 and $20.52 over the past year. Currently, Wall Street analysts expect the stock to reach $7.38 within the next 12 months. Cardlytics Inc [NASDAQ: CDLX] shares were valued at $3.16 at the most recent close of the market. An investor can expect a potential return of 133.54% based on the average CDLX price forecast.
Analyzing the CDLX fundamentals
The Cardlytics Inc [NASDAQ:CDLX] reported sales of 305.42M for trailing twelve months, representing a drop of -9.21%. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.5%, and Net Profit Margin reading is -0.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.8 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.11 points at the first support level, and at 3.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.21, and for the 2nd resistance point, it is at 3.27.
Ratios To Look Out For
It’s worth pointing out that Cardlytics Inc [NASDAQ:CDLX]’s Current Ratio is 1.77. In addition, the Quick Ratio stands at 1.77 and the Cash Ratio stands at 0.68. Considering the valuation of this stock, the price to sales ratio is 0.52, the price to book ratio is 0.74.
Transactions by insiders
Recent insider trading involved DeSieno Alexis, Chief Financial Officer, that happened on Oct 02 ’24 when 7487.0 shares were sold. Chief Legal & Privacy Officer, Lynton Nicholas Hollmeyer completed a deal on Oct 02 ’24 to sell 5936.0 shares. Meanwhile, Chief Executive Officer Gupta Amit sold 7543.0 shares on Oct 02 ’24.
